Welcome to Coloplast's Investor Relations site
Go to content.
Picture of Stina holding flowers. Stina is an influencer in Sweden, creates awareness around living with an ostomy.
Stina - influencer in Sweden, creates awareness around living with an ostomy

Welcome to Coloplast's
Investor Relations site


Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate health care. Our business includes Ostomy Care, Continence Care, Wound and Skin Care and Interventional Urology. We operate globally and employ about 12,500 employees.

On this site you can read about our most recent news and financial results, upcoming events and much more.

picture of Coloplast Annual report

View our latest 9M 2020/21 results
and the Annual Report 2019/20

See all reports

FY 2020/21 earnings release
conf. call on 1 November 2021

Access the event details here

picture of woman looking at our missions in a paper

Read the Q4 2020/21 
pre-close brief

Pre-close briefs

picture of notebook, keycard and computer on a desk

See the latest estimates for
Q3 2020/21 and FY 2020/21

Consensus estimates

Picture of a man holding a pen

Subscribe to the latest
published financial information

Subscription

picture of 2 persons in wheelchairs holding hands

Shareholders, view your
personal share information

Shareholder portal

picture of a man and a woman walking with their bikes

ESG investors, read our
sustainability presentation

Sustainability

Picture of the Investor relation team. From left to right: Otto, Ellen, Aleksandra and Hannah.

Contact Coloplast's
Investor Relations team

Contact

Letters to our shareholders

Our values define the way we think and act, both as individuals and as a company

Picture of Coloplast Chairman of the board, Lars Rasmussen

A message from the Chairman

Read the letter

Picture of Coloplast CEO, Kristian Villumsen

Our CEO's view on the business

Read more

"In September 2020 we launched our new Strive25 strategy with ambitious long-term financial targets of 7-9% organic growth and more than 30% EBIT margin."

Lars Rasmussen Chairman of the Board of Directors

 

"Strive25 will drive value creation through Sustainable Growth Leadership with a clear emphasis on Innovation, US and China."

Kristian Villumsen President & CEO

Coloplast user videos

Coloplast is built on the ability to listen to users’ needs – and respond with solutions that make their lives easier

Video of influencer Stina from Sweden

Stina's story

Ostomy care user
Video of Continence care user Tabitha.

Tabitha's story

Continence care user
Video of Wound & Skin care user Flemming.

Flemming's story

Wound and skin care user
Video of Interventional Urology user Brian.

Brian's story

Interventional urology user